Literature DB >> 21222097

Quit smoking and reduce surgical complications.

Jon Karlsson.   

Abstract

Mesh：

Year:  2011        PMID： 21222097     DOI： 10.1007/s00167-010-1385-9

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN： 0942-2056            Impact factor:   4.342


× No keyword cloud information.
  4 in total

1.  May smokers and overweight patients be treated with a medial open-wedge HTO? Risk factors for non-union.

Authors:  Gebhart Meidinger; Andreas B Imhoff; Jochen Paul; Chlodwig Kirchhoff; Martin Sauerschnig; Stefan Hinterwimmer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-12-11       Impact factor: 4.342

2.  Long-term effects of a preoperative smoking cessation programme.

Authors:  Nete M Villebro; Tom Pedersen; Ann M Møller; Hanne Tønnesen
Journal:  Clin Respir J       Date:  2008-07       Impact factor: 2.570

3.  Effect of smoking cessation intervention on results of acute fracture surgery: a randomized controlled trial.

Authors:  Hans Nåsell; Johanna Adami; Eva Samnegård; Hanne Tønnesen; Sari Ponzer
Journal:  J Bone Joint Surg Am       Date:  2010-06       Impact factor: 5.284

4.  Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial.

Authors:  David Lindström; Omid Sadr Azodi; Andreas Wladis; Hanne Tønnesen; Stefan Linder; Hans Nåsell; Sari Ponzer; Johanna Adami
Journal:  Ann Surg       Date:  2008-11       Impact factor: 12.969
  4 in total
  2 in total

Review 1.  Infections after high tibial osteotomy.

Authors:  Konstantinos Anagnostakos; Philipp Mosser; Dieter Kohn
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-06-23       Impact factor: 4.342

2.  The influence of lifestyle (smoking and body mass index) on wound healing and long-term recurrence rate in 534 primary pilonidal sinus patients.

Authors:  Heidi Sievert; Theo Evers; Edouard Matevossian; Christian Hoenemann; Sebastian Hoffmann; Dietrich Doll
Journal:  Int J Colorectal Dis       Date:  2013-06-20       Impact factor: 2.571
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.